Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Oral and IV Rolapitant
NCT02285647Phase 1Completed
- Start
- Sep 2014
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of rolapitant in chemotherapy-induced nausea and vomiting (CINV) (2 arms). Primary endpoint: Area Under the Plasma Concentration-Time Curve from Time 0 to Last Quantifiable Concentration. Started Sep 2014; status: completed.
02
Drugs
rolapitant
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT02285647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02285647.